Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/InspireMD, Inc/ 8-K

Current Report · Items 5.02, 9.01 · 8-K

InspireMD, Inc

NSPRNASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02. Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On June 26, 2026, Mr. Raymond W. Cohen, a Class III member of the board of directors (the “Board”) of InspireMD, Inc.…

Filed Jul 2, 2026Accepted Jul 2, 2026, 5:00 PM EDTCIK 1433607Accession 0001493152-26-031945
View company →Permanent SEC source ↗
Share

Company context

InspireMD seeks to utilize its proprietary MicroNet ™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.

Current securities

NSPRNASDAQ · EQUITY · Current
Historical securities (4)
NSPRWNASDAQ · WARRANT · Historical · closed Dec 3, 2024NSPR.WSAMEX · WARRANT · Historical · closed Jun 7, 2021NSPR.WS.BNYSE_AMERICAN · WARRANT · Historical · closed Jun 7, 2021NSPRZNASDAQ · WARRANT · Historical · closed Mar 14, 2022

Recent company filings

  1. 4 filingSep 23, 2026
  2. 4 filingSep 23, 2026
  3. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD DisclosureSep 21, 2026
  4. Results of Operations and Financial ConditionAug 17, 2026
  5. 10-Q filingAug 14, 2026

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On June 26, 2026, Mr. Raymond W. Cohen, a Class III member of the board of directors (the “Board”) of InspireMD, Inc. (the “Company”), a member of the Audit Committee of the Board and a member of the Compensation Committee of the Board, tendered his resignation from the Board, effective July 1, 2026. Mr. Cohen’s resignation from the Board was for personal considerations and not due to any disagreement with the Company, the Board or the management of the Company on any matter relating to the Company’s operations, policies, practices or otherwise. The Nominating and Corporate Governance Committee of the Board intends to identify and evaluate suitable candidates to fill the vacancy created by Mr. Cohen’s resignation.